Drugs / ACYW135 Meningococcal Polysaccharide Vaccine
ACYW135 Meningococcal Polysaccharide Vaccine
also known as
tetravalent A/C/Y/W135 polysaccharide vaccine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02867319 | Mar → Jul 2016 | meningococcal infection | Beijing Chaoyang District Centre for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01661751 | May 2006 | meningitis | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00271479 | Jun 2004 → Nov 2006 | meningococcal meningitis | Epicentre | Completed | Mixed |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06337071 Comparator | Mar → Jun 2024 | meningococcal meningitis | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACYW135 Meningococcal Polysaccharide Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01661751 ↗ |
| Known as | tetravalent A/C/Y/W135 polysaccharide vaccine | “the tetravalent A/C/Y/W135 polysaccharide vaccine (TPSV)” NCT00271479 ↗ |
| Modality | Vaccine | “fractional dose tetravalent meningococcal polysaccharide vaccine” NCT00271479 ↗ |